Etoposide or alkylating agents should get complete blood counts (CBCs) yearly for evidence of myelodysplasia or a secondary leukemia.

依托泊苷或者烷化疗应该每年接受全血细计数检查，以监测骨髓发或继发性白血病发生迹象。